Companies: 10,795·Total market cap: $144.5T
Revance Therapeutics, Inc.

Revance Therapeutics, Inc.

RVNCNASDAQHealthcare
$3.65
+$0.00(+0.00%)
Market Cap$381023500
P/E Ratio
52W High$7.56
52W Low$2.3
Overview

Revance Therapeutics, Inc.(RVNC)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · RVNC · 截至 Jun 10, 2026

关键指标

EPS (TTM)rvnc eps ttm · rvnc earnings per shareEarnings history
PE Ratio (TTM)rvnc pe ratio ttm · rvnc price to earningsPE Ratio deep dive
Revenue (TTM)rvnc revenue ttm · rvnc annual revenueFull revenue history
Dividend Yield不分红does rvnc pay dividends · rvnc dividend yieldDividend history
Shares Outstandingrvnc shares outstanding · rvnc floatShares outstanding history
Next EarningsTBArvnc earnings date · rvnc next earningsEarnings history

关于 Revance Therapeutics, Inc.

CEOMark J. Foley
IPO DateFeb 6, 2014
Employees597
CountryUS

Revance Therapeutics, Inc. is a biotechnology company specializing in the research, manufacturing, and marketing of neuromodulators for diverse aesthetic and therapeutic uses across both domestic and …

what is revance therapeutics, inc. · rvnc stock overview · revance therapeutics, inc. company profile · who is revance therapeutics, inc. ceo · rvnc NASDAQ · revance therapeutics, inc. headquarters · revance therapeutics, inc. business segments

关于股票概览与关键数据

Revance Therapeutics, Inc.(RVNC)是 Biotechnology 行业的 Healthcare 类公司,于 Feb 6, 2014 在 NASDAQ 上市。截至最近交易日,RVNC 股价为 $3.65,市值约为 $381.0M。过去12个月累计回报 —,年初至今回报 —。

常见问题

截至最近一个交易日,Revance Therapeutics, Inc.(RVNC)股价为 $3.65,在 NASDAQ 上市,52周区间为 $2.30 – $7.56。

RVNC 最新股价RVNC quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 10, 2026本内容不构成投资建议